Norway Polymerase Chain Reaction Market Size & Outlook

The polymerase chain reaction market in Norway is expected to reach a projected revenue of US$ 58.7 million by 2030. A compound annual growth rate of -4.8% is expected of Norway polymerase chain reaction market from 2024 to 2030.
Revenue, 2023 (US$M)
$83.0
Forecast, 2030 (US$M)
$58.7
CAGR, 2024 - 2030
-4.8%
Report Coverage
Norway

Norway polymerase chain reaction market, 2018-2030 (US$M)

Norway

Norway polymerase chain reaction market highlights

  • The Norway polymerase chain reaction market generated a revenue of USD 83.0 million in 2023 and is expected to reach USD 58.7 million by 2030.
  • The Norway market is expected to grow at a CAGR of -4.8% from 2024 to 2030.
  • In terms of segment, conventional pcr was the largest revenue generating type in 2023.
  • Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.


Polymerase chain reaction market data book summary

Market revenue in 2023USD 83.0 million
Market revenue in 2030USD 58.7 million
Growth rate-4.8% (CAGR from 2023 to 2030)
Largest segmentConventional pcr
Fastest growing segmentConventional PCR
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationConventional PCR
Key market players worldwideThermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth


Other key industry trends

  • In terms of revenue, Norway accounted for 0.3% of the global polymerase chain reaction market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2030.
  • Norway is the fastest growing regional market in Europe and is projected to reach USD 58.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Polymerase Chain Reaction Market Scope

Polymerase chain reaction market segmentation & scope
Conventional PCR
Others
Consumables & Reagents
Instruments
Software & Services
Pathology testing
Oncology testing
Blood screening
Others
Research
Forensic and others
Food
Others

Polymerase Chain Reaction Market Companies

Name Profile # Employees HQ Website

Norway polymerase chain reaction market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.


Conventional pcr was the largest segment with a revenue share of 8.07% in 2023. Horizon Databook has segmented the Norway polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Norway polymerase chain reaction market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Norway polymerase chain reaction market databook

  • Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Norway polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into Norway polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Norway polymerase chain reaction market size, by type, 2018-2030 (US$M)

Norway Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)

Norway polymerase chain reaction market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more